Sources Say GlaxoSmithKline in Talks to Acquire Human Genome Sciences -Reuters
16 July 2012 - 5:49AM
Dow Jones News
GlaxoSmithKline PLC (GSK, GSK.LN) is in talks to acquire Human
Genome Sciences Inc. (HGSI) in a $2.6 billion deal, Reuters reports
on its website Sunday, citing "sources familiar with the
situation."
Citing one of the sources, Reuters reported that GlaxoSmithKline
could sweeten the deal slightly, and that an announcement could
come as early as Monday.
A spokesman from GlaxoSmithKline declined to comment, Reuters
said, adding Human Genome Sciences officials were not immediately
available.
Full story at
http://www.reuters.com/article/2012/07/15/us-humangenome-glaxosmithkline-idUSBRE86E08P20120715
-Write to copydesk@dowjones.com
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
From Apr 2024 to May 2024
Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Human Genome Sciences, Inc. (MM) (NASDAQ): 0 recent articles
More Human Genome Sciences Inc. News Articles